Back to Trades
Other4
STERIS plc
STE
Total Value
$526.5K
Company Information
- Company Name
- STERIS plc
- Ticker Symbol
- STE
- CIK
- 0001757898
Insider Information
- Role
- Director
- Location
- DUBLIN 2, L2
Director
Filing Details
- Filing Date
- Aug 15, 2025
- Transaction Date
- Aug 13, 2025
- Accession Number
- 0001628280-25-040522
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Aug 13, 2025 | Ordinary Shares | 4,110 | $64.05 | Exercise | $263.2K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Aug 13, 2025 | Derivative | 4,110 | $64.05 | Exercise | $263.2K |
Footnotes
- (F1)Pursuant to Rule 16a-1(a)(2)(ii)(B) of the Securities Exchange Act of 1934, as amended, Mr. Breeden in his capacity as managing member, as well as chairman and chief executive officer of Breeden Capital Management LLC and as the managing member of Breeden Capital Partners LLC, may be deemed to be the indirect beneficial owner of the ordinary shares owned by the Fund and its General Partner, and may be deemed to have beneficial ownership of all such shares. Mr. Breeden disclaims beneficial ownership over 1,358 of these shares held by Breeden Partnership LLP.
- (F2)Richard C. Breeden is the managing member of Breeden Capital Partners LLC, and managing member and chairman and chief executive officer of Breeden Capital Management LLC. Breeden Capital Partners LLC (the "General Partner") is in turn the general partner of Breeden Partners L.P. (the "Fund").
- (F3)This option to purchase 4,110 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,110 ordinary shares for $64.05 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.